Navigation Links
Benefits and Risks of Asthma Treatment Questioned

Government guidelines on the treatment of asthma have long recommended inhaled corticosteroid (ICS) therapy as the best treatment for people with persistent forms of the condition.But reports about side effects //of these drugs have led many people -- including parents of asthmatic children -- to question their use. Specifically, ICS has been linked to growth retardation in children, weak bones in children and adults, skin thinning, and eye problems.

Now leading scientists hope to put those fears to rest. Three medical groups -- the American College of Chest Physicians, the American Academy of Allergy, Asthma, and Immunology, and the American College of Allergy, Asthma, and Immunology -- have teamed up to publish a systematic review of the medical evidence on ICS therapy and related side effects. Their conclusion is that the therapy is safe and effective and should remain the gold standard of treatment.

According to the report, published :
?h ICS therapy is not associated with bone thinning in children. ?h ICS therapy is linked to skin thinning and bruising in both adults and children, but the effects are mostly related to dose, length of use, and the gender of the patient. ?h ICS therapy is associated with a decrease in childhood growth rates, but the effect is small and studies suggest it may not persist with long-term therapy. Adult height of asthmatic children treated with ICS therapy is not substantially different from adult height attained by nonasthmatic children.

Conclusions could not be drawn on the effect of ICS therapy on bone thinning in adults or eye problems such as cataracts and glaucoma due to a lack of sufficient medical evidence.

Researchers from Thomas Jefferson University in Philadelphia, say, ?§After a systematic and accurate review of the proven risks, we can say with confidence that the majority of evidence supports the conclusion that the clinical effectiveness of ICS therapy decidedly outweighs t
'"/>




Page: 1 2

Related medicine news :

1. Benefits in fertility procedures
2. Benefits of Vitamin Supplements Unclear
3. Benefits of Eating Whole Grains, Fruits and Vegetables
4. Benefits of Nitric Oxide in the Treatment of Premature Infants
5. Benefits Of The Worlds Most Widely Used Beverage
6. Drug In Asthma inhaler Found To Counteract Benefits
7. The Benefits Of Keyhole Surgery
8. The Benefits Of A Stretch
9. A Reduction In Calories Found To Yield More Benefits
10. The Benefits Of Soy
11. Benefits Of Fruits and Veggies
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Benefits and Risks Asthma Treatment Questioned

(Date:3/1/2015)... York, New York (PRWEB) March 01, 2015 ... Profemur hip lawsuit (( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to ... the defense must prepare a witness to provide ... played in the development of the Profemur device, ... filed in U.S. District Court, Northern District of ...
(Date:3/1/2015)... ERISAPros is pleased to ... to the professional staff of its Compliance Department. , ... Ohio State University-Mortiz College of Law. Prior to joining ... with several Fortune 500 companies as well as several ... benefits. Her experiences range from benefit plan design, vendor ...
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims ... platform and gears towards the goal for a better ... group talks in smaller groups will be held after ... Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women and ... youths. , Young adults aged between 18-30 ...
(Date:2/28/2015)... 2015 Gerald “Solutionman” Haman surveyed over ... barriers to innovative thinking. “The #1 block was ... of tools,” reports Haman, who created the Thinkubator Innovation ... people felt that they did not have enough time ... resources to stimulate innovation. , Solutionman’s monthly “Accelerating Innovation ...
(Date:2/28/2015)... NJ (PRWEB) February 28, 2015 ... a good time to remind ourselves and others ... ignored, say Atlantic NeuroSurgical Specialists (ANS). , Concussions ... which account for 75% of TBIs. There are ... concussion may sound benign, but it is a ...
Breaking Medicine News(10 mins):Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... , WASHINGTON , Jan. 12 ... Tobacco Control 2009 report, which grades the strength ... These illnesses are now at the heart of America,s chronic disease ... made major strides but still has significant room for progress. Most ...
... ... for Clinical Trials announces NetPRO – ePRO on netbooks! , ... Scottsdale, AZ (PRWEB) January 12, 2010 -- ... With NetPRO, assisTek once again leads the ePRO and clinical trials market with ...
... ... file system, and SharePoint archiving solutions for electronic discovery, litigation support, compliance, and storage ... annual growth of over 300% in the key international markets. , ... Milpitas, CA (PRWEB) January 12, 2010 ...
... ... their long list of services to include DNA Infidelity Testing. This test can be used ... price includes overnight shipping to the laboratory. Results are ready in four business days. ... Dallas, TX (Vocus) January 11, 2010 -- ...
... , KNOXVILLE, Tenn., Jan. 11 TeamHealth Holdings, ... the underwriters of its recent initial public offering of common ... additional 1,995,000 shares of common stock from the Company at ... to use the additional net proceeds of approximately $22.5 million ...
... A 21-gene test that predicts whether early stage breast cancer ... on treatment decisions by patients and doctors alike. The ... percent of cases, while 27 percent of patients changed their ... both doctors and patients was to avoid chemotherapy. The ...
Cached Medicine News:Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 2Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 3Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 4Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 5Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 6Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 7Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 8Health News:ePRO on Netbooks (NetPRO) - The BEST ePRO Solution for Clinical Trials in 15 Years 2Health News:ePRO on Netbooks (NetPRO) - The BEST ePRO Solution for Clinical Trials in 15 Years 3Health News:ePRO on Netbooks (NetPRO) - The BEST ePRO Solution for Clinical Trials in 15 Years 4Health News:MessageSolution Awards Global Partners for Outstanding Global Support and Strategic Market Growth 2Health News:MessageSolution Awards Global Partners for Outstanding Global Support and Strategic Market Growth 3Health News:MessageSolution Awards Global Partners for Outstanding Global Support and Strategic Market Growth 4Health News:MessageSolution Awards Global Partners for Outstanding Global Support and Strategic Market Growth 5Health News:MessageSolution Awards Global Partners for Outstanding Global Support and Strategic Market Growth 6Health News:MessageSolution Awards Global Partners for Outstanding Global Support and Strategic Market Growth 7Health News:ANY LAB TEST NOW North Dallas | “Is My Spouse Cheating On Me?” 2Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 2Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 3Health News:TeamHealth Announces Exercise of Over-Allotment Option for Previously Announced Initial Public Offering 4Health News:Breast cancer multigene test helping patients avoid chemotherapy 2
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... , Feb. 27, 2015 An aggressive campaign ... cut the rate of infection with a dangerous drug-resistant ... Clostridium difficile, or C.diff, is a bacterium ... inflammation of the colon. A recent article in the ... difficile Infection in the United States ...
(Date:2/27/2015)... , Feb. 27, 2015   Synageva BioPharma ... a biopharmaceutical company developing therapeutic products for rare ... (NORD™), the European Organisation for Rare Diseases™ (EURORDIS™), ... world in observing Rare Disease Day. ... patient organizations, industry, and other participants conduct special ...
Breaking Medicine Technology:Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... Nov. 22, 2011 Cardica, Inc. (Nasdaq: CRDC ... under its distribution agreement and loan commitment with Century Medical. ... the $4 million loan commitment from Century. Under the terms ... balance of all amounts drawn by Cardica will be due ...
... 2011 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... and Drug Administration (FDA) has accepted for review the ... for Subcutaneous Use for the prevention of gout flares ... Drug User Fee Act (PDUFA), the goal for a ...
Cached Medicine Technology:Cardica Achieves Second Milestone Under Century Distribution Agreement 2Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 2Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 3Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 4Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 5Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 6Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 7Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 8
Angled for temporal approach. Solid 14 mm blades. Dull finish....
Open 11 mm blades. Polished finish....
Open 10 mm blades. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Medicine Products: